Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zambetti

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
International Journal of Cancer|July 18, 2000
Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancerR Silvestrini, A Luisi, M Zambetti, et al.
Tumori|June 30, 1985
Accuracy of the double contrast enema in evaluation of the abdominal diffusion of ovarian carcinomaG Cozzi, L Balzarini, M Bellomi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiationM Zambetti, A Moliterni, C Materazzo, et al.
Breast Cancer Research and Treatment|June 16, 1999
Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'R Demicheli, R Miceli, C Brambilla, et al.
Tumori|December 10, 1999
Locally advanced breast cancer treated with primary chemotherapy: comparison between magnetic resonance imaging and pathologic evaluation of residual diseaseG Trecate, E Ceglia, F Stabile, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Combined sequential approach in locally advanced breast cancerM Zambetti, S Oriana, P Quattrone, et al.
La Radiologia Medica|August 4, 1998
[Locally advanced breast tumors. Role of magnetic resonance in the assessment of response to preoperative therapy and of neoplastic residue before the operation]G Trecate, E Ceglia, F Stabile, et al.
Clinical & Experimental Metastasis|April 1, 1983
T3b-T4 breast cancer: factors affecting results in combined modality treatmentsP Valagussa, M Zambetti, P Bignami, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Adjuvant CMF for node-negative and estrogen receptor-negative breast cancer patientsM Zambetti, G Bonadonna, P Valagussa, et al.
Breast Cancer Research and Treatment|January 1, 1996
Vinorelbine: an active, non cross-resistant drug in advanced breast cancer. Results from a phase II studyM Terenziani, R Demicheli, C Brambilla, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
International Journal of Cancer|July 18, 2000
Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancerR Silvestrini, A Luisi, M Zambetti, et al.
Tumori|June 30, 1985
Accuracy of the double contrast enema in evaluation of the abdominal diffusion of ovarian carcinomaG Cozzi, L Balzarini, M Bellomi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiationM Zambetti, A Moliterni, C Materazzo, et al.
Breast Cancer Research and Treatment|June 16, 1999
Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'R Demicheli, R Miceli, C Brambilla, et al.
Tumori|December 10, 1999
Locally advanced breast cancer treated with primary chemotherapy: comparison between magnetic resonance imaging and pathologic evaluation of residual diseaseG Trecate, E Ceglia, F Stabile, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 4, 1999
Combined sequential approach in locally advanced breast cancerM Zambetti, S Oriana, P Quattrone, et al.
La Radiologia Medica|August 4, 1998
[Locally advanced breast tumors. Role of magnetic resonance in the assessment of response to preoperative therapy and of neoplastic residue before the operation]G Trecate, E Ceglia, F Stabile, et al.
Clinical & Experimental Metastasis|April 1, 1983
T3b-T4 breast cancer: factors affecting results in combined modality treatmentsP Valagussa, M Zambetti, P Bignami, et al.
Journal of the National Cancer Institute. Monographs|January 1, 1992
Adjuvant CMF for node-negative and estrogen receptor-negative breast cancer patientsM Zambetti, G Bonadonna, P Valagussa, et al.
Breast Cancer Research and Treatment|January 1, 1996
Vinorelbine: an active, non cross-resistant drug in advanced breast cancer. Results from a phase II studyM Terenziani, R Demicheli, C Brambilla, et al.
Pageof 5